DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
163.37
+1.97 (1.22%)
Nov 21, 2024, 11:24 AM EST - Market open
DaVita Revenue
DaVita had revenue of $3.26B in the quarter ending September 30, 2024, with 4.56% growth. This brings the company's revenue in the last twelve months to $12.67B, up 6.34% year-over-year. In the year 2023, DaVita had annual revenue of $12.14B with 4.57% growth.
Revenue (ttm)
$12.67B
Revenue Growth
+6.34%
P/S Ratio
1.11
Revenue / Employee
$180,952
Employees
70,000
Market Cap
13.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.14B | 530.25M | 4.57% |
Dec 31, 2022 | 11.61B | -8.90M | -0.08% |
Dec 31, 2021 | 11.62B | 68.19M | 0.59% |
Dec 31, 2020 | 11.55B | 162.13M | 1.42% |
Dec 31, 2019 | 11.39B | -23.67M | -0.21% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG | 21.46B |
Universal Health Services | 15.42B |
Solventum | 8.22B |
Dr. Reddy's Laboratories | 3.58B |
Genmab | 2.97B |
BioMarin Pharmaceutical | 2.75B |
Revvity | 2.72B |
Globus Medical | 2.48B |
DVA News
- 6 days ago - DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation - Seeking Alpha
- 9 days ago - DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health - PRNewsWire
- 12 days ago - DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 - PRNewsWire
- 22 days ago - DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - DaVita misses third-quarter profit estimates on higher costs - Reuters
- 22 days ago - DaVita Inc. 3rd Quarter 2024 Results - PRNewsWire
- 24 days ago - DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program - PRNewsWire
- 4 weeks ago - DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024 - PRNewsWire